NPI registry status
Active
2026 NPPES data Specialist NPI 1689853947 MD
Verify on CMS → Cyriac Chemplavil, MD
Specialist in Henderson, Nevada.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 69,658 in Specialist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
3K
Medicare Part D claims · 522 beneficiaries · Specialist avg: 1K
Generic prescribing
0%
generic claims · 77% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
66.5/100
▼ 17 pts below national avg 83.1 · Mid-tier
Industry payments
$2.4K
103 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2023
Compiled from official public sources by the PlainDoctor editorial team.
What the federal data shows
Cyriac Chemplavil, MD reported a CMS MIPS final score of 66.5/100 - below the 83.1 national average - and filed 3,493 Medicare Part D claims in 2023.
- 66.5/100
- MIPS score · -17 vs avg
- 3K
- Part D claims, 2023
- 0%
- generic prescribing
- $2.4K
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Cyriac Chemplavil, MD's MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
67 7th percentile higher than 7% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Cyriac Chemplavil, MD sits
This provider among specialist peers
Across the 4,869 specialist providers who report both Medicare Part D prescribing and a MIPS quality score, Cyriac Chemplavil, MD writes more Part D claims than 84% of them and scores higher on MIPS quality than 18% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one specialist peer from a representative sample of 60; the gold marker is Cyriac Chemplavil, MD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Cyriac Chemplavil, MD?
Below national averagePrimary specialty
Specialist
Medicare Part D claims
3,493 137% vs specialty avg
MIPS final score
66.5/100 16.6 pts vs avg
Specialty distribution in Nevada
How Specialist compares to other specialties among Nevada providers
Medicare quality performance, MIPS
Cyriac Chemplavil, MD's 2023 MIPS final score plotted against the Specialist national average
- MIPS Final Score
- 66.5/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Specialist) - 66.5/100 vs national avg 83.1
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Cyriac Chemplavil, MD appears in the CMS NPPES registry as a Specialist provider holding MD credentials at 8965 S PECOS RD, Henderson, NV, 89074, with a listed phone of (702) 735-4094. NPI 1689853947 was issued on 11/02/2007.
Medicare Part D records for calendar year 2023 show 3,493 prescription claims written by this provider, covering 522 Medicare beneficiaries and totaling roughly $3.3 million in drug spend, split 77% brand-name and 0% generic by claim count. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 66.5/100 for the 2023 performance year (Quality 46.8, Cost 55.4), compared with the national average of 83.1.
Specialist is a high-volume specialty nationwide, with 69,658 enrolled providers across 55 states and an average of 1,474 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1689853947 |
|---|---|
| Specialty | Specialist |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 11/02/2007 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
66.4986
Final Score
Avg: 83.1
46.8175
Quality
55.425
Cost
77
Promoting Interoperability
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Cyriac Chemplavil, MD. Source: openpaymentsdata.cms.gov.
Total received
$2.4K
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Brand-heavy
Cyriac Chemplavil, MD - brand share 77.0%
Specialist average
77% brand-name claims vs 0% generic, on 3,493 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
3,493
Total Claims
$3.3M
Total Drug Cost
522
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 4,746
- Total Day Supply
- 133,649
- Brand vs Generic
- 77% brand / 0% generic
- Brand Drug Cost
- $3.1M
- Antibiotic Claims
- 134
Patient Demographics
- Average Patient Age
- 73.8 years
- Avg HCC Risk Score
- 1.74
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 37, 65-74: 245, 75-84: 194, 85+: 46
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Cyriac Chemplavil, MD prescribes most
Top Medicare Part D drugs by claim count, 2023
- Trelegy Ellipta
Trelegy Ellipta
699 claims
- Albuterol Sulfate …
Albuterol Sulfate Hfa
405 claims
- Symbicort 253
Symbicort
253 claims
- Breztri Aerosphere 210
Breztri Aerosphere
210 claims
- Prednisone 192
Prednisone
192 claims
- Breo Ellipta 151
Breo Ellipta
151 claims
- Spiriva Respimat 150
Spiriva Respimat
150 claims
- Stiolto Respimat 102
Stiolto Respimat
102 claims
| Drug | Claims |
|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 699 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 405 |
| Symbicort Budesonide/Formoterol Fumarate | 253 |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 210 |
| Prednisone | 192 |
| Breo Ellipta Fluticasone/Vilanterol | 151 |
| Spiriva Respimat Tiotropium Bromide | 150 |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 102 |
| Montelukast Sodium | 97 |
| Methylprednisolone | 88 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Specialist Overview
How Cyriac Chemplavil, MD fits within the Specialist landscape nationally.
69,658
Specialist Providers in US
55
States with Specialist
1,474
Avg Claims per Provider
Cyriac Chemplavil, MD's 3,493 claims are above the specialty average of 1,474.
Nearby Specialist Providers in Nevada
Other clinicians with the same primary specialty enrolled in Nevada, drawn from the same CMS NPPES roster as Chemplavil.
Dr. Karen Abbott
MD
Reno, NV
Dr. Gary Abrass
M.D.
Reno, NV
Dr. George Addison
M.S. ED.
Las Vegas, NV
Dr. Miriam Adelson
M.D.
Las Vegas, NV
Dr. Paparao Adusumilli
M.D.
Nellis Afb, NV
Compare Specialist nationally: see state-by-state distribution →
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Nevada medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Specialist peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
How to Find a Doctor
Step-by-step guide to choosing a provider
Verify Credentials
Check NPI, board certification & license status
Medical Specialties Explained
Who treats what and how specialties differ
Understanding Medicare Claims Data
What prescribing data reveals about a provider
In-Network vs Out-of-Network
How insurance networks affect your costs
Telehealth Guide
Virtual care options and coverage in 2026
Explore Nevada
Frequently Asked Questions
What is Cyriac Chemplavil, MD's specialty? ▼
Cyriac Chemplavil, MD specializes in Specialist and practices in Henderson, Nevada. Credentials: MD.
How much does Cyriac Chemplavil, MD prescribe under Medicare Part D? ▼
In 2023, Cyriac Chemplavil, MD wrote 3,493 Medicare Part D claims totaling $3.3M in drug costs for 522 beneficiaries.
What is Cyriac Chemplavil, MD's Medicare quality score? ▼
Cyriac Chemplavil, MD has a CMS MIPS Final Score of 66.5/100 (Quality: 46.8, Cost: 55.4). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Cyriac Chemplavil, MD located? ▼
Cyriac Chemplavil, MD is located at 8965 S PECOS RD, Henderson, NV, 89074. Phone: (702) 735-4094.
What is Cyriac Chemplavil, MD's NPI number? ▼
Cyriac Chemplavil, MD's National Provider Identifier (NPI) is 1689853947, issued on 11/02/2007.
Does Cyriac Chemplavil, MD prescribe more brand-name or generic drugs? ▼
Cyriac Chemplavil, MD's prescribing is 77% brand-name and 0% generic drugs by claim count, with $3.1M in brand drug costs.
How many Specialist providers are there in the US? ▼
There are 69,658 Specialist providers across 55 states in the US. The average Specialist provider writes 1,474 Medicare Part D claims per year.
What drugs does Cyriac Chemplavil, MD prescribe most often? ▼
Based on 2023 Medicare Part D data, Cyriac Chemplavil, MD's most frequently prescribed drugs include Trelegy Ellipta, Albuterol Sulfate Hfa, Symbicort. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Cyriac Chemplavil, MD accept Medicare? ▼
Cyriac Chemplavil, MD appears in CMS Medicare data with 3,493 Part D claims and 522 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Cyriac Chemplavil, MD's credentials? ▼
Cyriac Chemplavil, MD's NPI is 1689853947 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Compiled from official public sources by the PlainDoctor editorial team.